Aerogen is an innovative medical device and drug delivery company specialising in the design, manufacture and marketing of aerosol drug delivery systems, aimed predominately at the critical care respiratory market. Aerogen’s patented vibrating mesh aerosol technology is an integral part of its drug delivery systems; the technology allows drugs to be nebulised into a fine particle mist that can be absorbed through the lungs while maintaining drug integrity. Founded in 1997, Aerogen has grown to become the global leader in acute care aerosol drug delivery equipment and today its nebuliser products play a critical role in treating patients on life-support ventilation, as well as home care offerings in over 65 counties worldwide. Aerogen currently employs a growing team of 87 staff, primarily science and engineering graduates and PhDs.